Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 473,034	$ 28,258,219
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	0	(77,570)
Change in net unrealized (appreciation) depreciation of investments		(5,346,656)	$ 3,349,572
Net amortization of investment discounts and premiums	(526,436)	(3,167,347)
Interest and dividend income paid in kind	(128,409)	(694,111)
Amortization of deferred debt issuance costs	109,094	193,554
Changes in assets and liabilities:
Purchase of investments	(217,342,907)	(248,934,358)
Proceeds from disposition of investments	7,093,801	64,848,048
Decrease (increase) in interest, dividends and fees receivable	(1,265,323)	(2,134,446)
Decrease (increase) in receivable for investments sold	(22,548)	(596,291)
Decrease (increase) in prepaid expenses and other assets	(283,390)	(489,986)
Increase (decrease) in payable for investments purchased	7,174,463	6,686,087
Increase (decrease) in interest and debt related payables	1,090,190	1,075,837
Increase (decrease) in reimbursements due to the Investment Adviser	48,566	199,376
Increase (decrease) in accrued expenses and other liabilities	1,149,618	214,362
Net cash provided by (used in) operating activities	(199,080,675)	(159,965,282)
Financing activities
Proceeds from common shares sold	118,655,300	91,787,065
Contribution received in advance	4,950,000	11,924,839
Draws on credit facilities	135,000,000	121,000,000
Repayments of credit facility draws	(40,000,000)	(60,000,000)
Payments of debt issuance costs	(1,888,726)	(320,295)
Dividends paid in cash to shareholders	(2,170)	(1,666,198)
Net cash provided by (used in) financing activities	216,714,404	162,725,411
Net increase (decrease) in cash and cash equivalents (including restricted cash)	17,633,729	2,760,129
Cash and cash equivalents (including restricted cash) at beginning of period	0	17,633,729
Cash and cash equivalents (including restricted cash) at end of period	17,633,729	20,393,858	$ 17,633,729
Supplemental cash flow information
Interest payments	1,064,214	7,128,811
Excise tax payments	0	18,395
Distribution payable	1,440,887	3,651,224
Reinvestment of dividends during the period	$ 1,819,100	$ 17,295,327